Is Rhythm Pharmaceuticals, Inc. (RYTM) A Good Stock To Buy Now? 

Is RYTM a good stock to buy? We came across a bearish thesis on Rhythm Pharmaceuticals, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bears’ thesis on RYTM. Rhythm Pharmaceuticals, Inc.'s share was trading at $87.72 as of April 20th.

[caption id="attachment_575378" align="aligncenter" width="750"] Pressmaster/Shutterstock.com[/caption]

Rhythm Pharmaceuticals (RYTM) is a rare-disease biotech built almost entirely around setmelanotide, an MC4R agonist targeting genetic and hypothalamic obesity, but its concentrated strategy creates a fragile...